# VistaGen Therapeutics, Inc. (VTGN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VTGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 808.9K | $ -68.65M | $ -61.83M | $ 1.43M | $ 50.92M |
| 2024 | $ 734.0K | $ -49.72M | $ -41.27M | $ 1.71M | $ 81.12M |
| 2023 | $ 1.13M | $ -34.67M | $ -28.47M | $ 2.25M | $ 123.28M |
| 2022 | $ -406.5K | $ -71.17M | $ -64.84M | $ 3.15M | $ 20.67M |
| 2021 | $ 1.80M | $ -44.32M | $ -41.81M | $ 3.14M | $ 79.98M |
| 2020 | $ 825.0K | $ -19.10M | $ -12.26M | $ 3.90M | $ 99.73M |
| 2019 | $ 0 | $ -29.98M | $ -21.61M | $ 4.18M | $ -6.09M |
| 2018 | $ 0 | $ -30.30M | $ -18.15M | $ 59.1K | $ 1.69M |
| 2017 | $ 0 | $ -17.26M | $ -10.75M | $ 56.3K | $ 10.26M |
| 2016 | $ 1.72M | $ -22.30M | $ -10.06M | $ 36.1K | $ 2.59M |
| 2015 | $ 0 | $ -63.10M | $ -6.17M | $ 104.5K | $ -1.60M |
| 2014 | $ 0 | $ -13.41M | $ -3.30M | $ 11.90M | $ -17.78M |
| 2013 | $ 0 | $ -6.99M | $ -3.76M | $ 6.39M | $ -11.67M |
| 2012 | $ 966.3K | $ -17.55M | $ -4.85M | $ 5.25M | $ -10.52M |
| 2011 | $ 1.28M | $ -13.48M | $ -4.19M | $ 3.31M | $ -4.76M |
| 2010 | $ 0 | $ -13.6K | $ -10.4K | $ 530 | $ -1.0K |
| 2009 | $ 0 | $ -33.3K | $ -34.5K | $ 500 | $ -124 |
| 2008 | $ 0 | $ -24.9K | $ -23.8K | $ 500 | $ 20.4K |
| 2007 | $ 0 | $ -12.6K | $ -3.3K | $ 0 | $ 0 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.28 |
| Current Ratio | 4.67 |

## Other views

- [Metrics](https://sponda.capital/en/VTGN.md)
- [Charts](https://sponda.capital/en/VTGN/charts.md)
- [Compare](https://sponda.capital/en/VTGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.